Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 17Uterine Cervical Neoplasms 9Endometrial Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Uterine Neoplasms 3Pancreatic Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Genital Neoplasms, Female 2Esophageal Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Trophoblastic Neoplasms 1Triple Negative Breast Neoplasms 1Thymus Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1

Interventions

Vacuum Curettage 2Drug Therapy 2Pemetrexed 1Methotrexate 1Letrozole 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hydatidiform Mole × Pemetrexed × Gynecologic × Clear all
NCT00190918 2007-08-09

A Trial for Patients With Gestational Trophoblastic Disease

Eli Lilly and Company

Phase 2 Completed
50 enrolled
Gynecologic

Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡